2019-11-15T15:23:28-06:00 2018-12-31 521446779 JOHNSON LAMBERT LLP 4242 SIX FORKS ROAD SUITE 1500 RALEIGH NC 27609 990 2018-01-01 030466352 THE GOG FOUNDATION INC GOGF 4107217126 2127 ESPEY COURT NO 100 CROFTON MD 21114 MARY C SHARP CHIEF FINANCIAL OFFICER 4107217126 2019-11-15 1 P01226973 9197196400 34.206.232.202 2019-11-15 15:23:23 ES P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 9C238F1B6484ABD2E08FB3ED1A4A2692AD2A909B 2018 2020-03-31 21:24:44Z LARRY J COPELAND MD 2127 ESPEY COURT NO 100 CROFTON MD 21114 32862630 0 X WWW.GOG.ORG X 2002 DC THE GOG FOUNDATION'S PRIMARY EXEMPT PURPOSE IS TO PROMOTE EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES. 10 10 33 11 123397 118908 5135505 3475111 17787205 27487443 1531727 1681193 0 47994 24454437 32691741 0 0 0 0 3569966 3840003 0 0 255854 17552325 29340621 21122291 33180624 3332146 -488883 83615240 75412609 24985371 20870061 58629869 54542548 X THE GOG FOUNDATION (GOG) IS A NON-PROFIT ORGANIZATION (NATIONAL) WITH THE PURPOSE OF PROMOTING EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES. THE FOUNDATION (GYNECOLOGIC ONCOLOGISTS, MEDICAL ONCOLOGISTS, PATHOLOGISTS, RADIATION ONCOLOGISTS, NURSES, STATISTICIANS, BASIC SCIENTISTS, QUALITY OF LIFE EXPERTS, DATA MANAGERS AND ADMINISTRATIVE PERSONNEL) IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. 0 0 32916837 27487443 THE FOUNDATION IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. IN 2018 THE GOG FOUNDATION, INC. CONDUCTED CLINICAL TRIALS THROUGH OUR 60 PLUS MEMBER INSTITUTIONS. THESE EXPENSES INCLUDED PROTOCOL DEVELOPMENT, REGULATORY AFFAIRS, MEETINGS TO REVIEW TRIAL DATA, TRIAL DEVELOPMENT THROUGH COMMITTEE FUNCTIONS AND OTHER INDIRECT RELATED EXPENSES. 32916837 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 68 0 1 33 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 10 10 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 MD X MARY C SHARP CFO 4107217126 2127 ESPEY COURT SUITE 100 CROFTON MD 21114 LARRY J COPELAND MD PRESIDENT 20.00 X X 0 0 0 PHILIP J DISAIA MD IMMEDIATE PAST PRESIDENT 1.00 X X 0 0 0 ROBERT S MANNEL MD VICE PRESIDENT 13.00 X X 0 0 0 THOMAS J HERZOG MD TREASURER 1.00 X X 0 0 0 DAVID G MUTCH MD SECRETARY 1.00 X X 0 0 0 CAROL AGHAJANIAN MD DIRECTOR (TO JUL '18) 1.00 X 0 0 0 ROBERT BURGER MD DIRECTOR (FROM JUL '18) 1.00 X 0 0 0 ROBERT L COLEMAN MD DIRECTOR 1.00 X 0 0 0 PAUL A DISILVESTRO DIRECTOR 1.00 X 0 0 0 PARVIZ HANJANI MD DIRECTOR 1.00 X 0 0 0 BRADLEY J MONK MD DIRECTOR 1.00 X 0 0 0 MARY C SHARP CHIEF FINANCIAL OFFICER 35.00 X 265505 0 42796 LAURA REESE EXECUTIVE DIRECTOR 35.00 X 234912 0 40618 DENISE MACKEY DIRECTOR OF ADMINISTRATION 35.00 X 158883 0 32883 MICHAEL POWERS GENERAL COUNSEL 35.00 X 251251 0 26031 KATHY SHUMAKER DIRECTOR OF DEVELOPMENT 35.00 X 123775 0 45497 CATHERINE GALOPPO ASSOCIATE DIRECTOR, INFO T 35.00 X 117398 0 30350 KATHLEEN CAMPBELL DIR, REGULATORY AFFAIRS 35.00 X 130526 0 31697 CHRISTINA NEFF DIR, PROTOCOL DEVELOPMENT 35.00 X 110606 0 50814 1392856 0 300686 8 0 1 0 0 3229007 246104 3475111 INDUSTRY REVENUE 900099 27348652 27348652 REGISTRATION FEES 900099 138791 138791 27487443 1682107 123397 1558710 169975 170889 -914 -914 -914 MISCELLANEOUS 900099 23997 23997 23997 23997 47994 32691741 27487443 123397 1605790 775597 417815 302893 54889 2318390 1244493 923369 150528 175143 95591 67497 12055 373600 207136 110510 55954 197273 111189 72185 13899 273599 273599 45593 45593 980916 596641 373675 10600 248800 126896 116309 5595 189480 189480 297578 233857 63721 271980 137705 119428 14847 291535 159453 116628 15454 138320 138320 PURCHASE SERVICE AGREEM 23362188 23362188 CONSORTIUMS 3008799 3008799 HONORARIA 293939 49100 239524 5315 OVERHEAD ALLOCATION 0 2833105 -2833105 -62106 59270 -38094 -83282 33180624 32916837 7933 255854 541218 280435 27443095 17373994 761171 470155 -2154 -520 5510 0 51636148 54126089 2543215 2432979 654437 696877 32600 32600 83615240 75412609 2276020 1716068 22709351 19153993 24985371 20870061 X 58629869 54542548 58629869 54542548 83615240 75412609 -488883 -3574441 0 X 0 1 X 1 1 1 X 10776461 6706548 5236856 5135505 3475111 31330481 10776461 6706548 5236856 5135505 3475111 31330481 31330481 1092099 1248612 1132952 1486285 1558710 6518658 21656 45781 85776 37116 115076 305405 54521 36704 11412 23997 126634 38281178 76227097 0.81840 0.87800 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 29093303 -3574441 -3574441 32667744 0 32667744 33180624 0 33180624 0 33180624 PART X, LINE 2: MANAGEMENT HAS CONCLUDED THAT GOG HAS PROPERLY MAINTAINED ITS EXEMPT STATUS, AND THERE ARE NO UNCERTAIN TAX POSITIONS AS OF DECEMBER 31, 2018 OR 2017. CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESTMENTS 888000 0 0 0 0 0 0 888000 0 888000 0 0 0 0 1 0 X X 0 0 0 0 0 0 0 0 0 MARY C SHARP CHIEF FINANCIAL OFFICER 256749 0 8756 0 0 0 26550 0 16246 0 308301 0 0 0 LAURA REESE EXECUTIVE DIRECTOR 227028 0 7884 0 0 0 23491 0 17127 0 275530 0 0 0 DENISE MACKEY DIRECTOR OF ADMINISTRATION 153465 0 5418 0 0 0 15888 0 16995 0 191766 0 0 0 MICHAEL POWERS GENERAL COUNSEL 243201 0 8050 0 0 0 25125 0 906 0 277282 0 0 0 KATHY SHUMAKER DIRECTOR OF DEVELOPMENT 118901 0 4874 0 0 0 12377 0 33120 0 169272 0 0 0 KATHLEEN CAMPBELL DIR, REGULATORY AFFAIRS 111109 0 19417 0 0 0 13053 0 18644 0 162223 0 0 0 CHRISTINA NEFF DIR, PROTOCOL DEVELOPMENT 106765 0 3841 0 0 0 11061 0 39753 0 161420 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE CFO BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST DISCLOSURE FORMS ARE REVIEWED ANNUALLY BY THE FOUNDATION CHAIR, AND ON AN INTERIM BASIS. THE FOUNDATION CHAIR REVIEWS ANNUAL FORMS NO LATER THAN NOVEMBER 1 OF EACH YEAR, AND INTERIM FORMS WITHIN 30 DAYS. THE CONFLICT IS MANAGED, REDUCED, OR ELIMINATED, AT LEAST ON AN INTERIM BASIS, WITHIN 60 DAYS OF ITS IDENTIFICATION. FORM 990, PART VI, SECTION B, LINE 15 OFFICER AND KEY EMPLOYEE SALARY IS APPROVED BY THE CEO AND TREASURER ANNUALLY, IN CONSULTATION WITH A COMPENSATION SURVEY WHICH IS OBTAINED PERIODICALLY. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AT RECEPTIONIST'S DESK.